Vaxcyte Inc (PCVX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.75B
Last updated: Nov 17, 2026 at 4:33 PM ET
Vaxcyte Inc (PCVX) Stock Chart
Vaxcyte (PCVX) has a latest price of $59.40 on Nov 17, 2026, 34.5% below its 52-week high of $90.75. Its price rose 22.0% over the past 12 months. The month-end price rose 165.1% over the 5 years through Oct 2026, a compound annual rate of 21.5%.
Price Chart
From Jun 2020 to Oct 2026, its highest month-end close was $114.27 in Sep 2024 and its lowest $18.57 in Apr 2021, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PCVX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PCVX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 6.2%, and over 6 months it rose 21.8%. The month-end price rose 29.0% over the 3 years through Oct 2026, a compound annual rate of 8.8%.
| Period | Change |
|---|---|
| 1 month | -6.7% |
| 3 months | -6.2% |
| 6 months | +21.8% |
| 12 months | +22.0% |
| 12 months, with dividends | +22.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +29.0% | +8.8% |
| 5 years | +165.1% | +21.5% |
Price by Year
Its best calendar year was 2022, when the price rose 101.6%, and its weakest was 2025, when it fell 43.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $62.03 | +34.4% |
| 2025 | $46.14 | -43.6% |
| 2024 | $81.86 | +30.4% |
| 2023 | $62.80 | +31.0% |
| 2022 | $47.95 | +101.6% |
| 2021 | $23.79 | -10.5% |
Trading Range
The price is 4.5% below its 50-day average of $62.23 and 2.9% above its 200-day average of $57.75.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $59.40 | |
| 52-week high | $90.75 | -34.5% |
| 52-week low | $42.40 | +40.1% |
| 50-day average | $62.23 | -4.5% |
| 200-day average | $57.75 | +2.9% |
Price Risk
Over 3 years, its largest fall from a peak was 76.2%.
| Measure | Value |
|---|---|
| 1-year beta | 1.28 |
| Largest fall, 1 year | -28.0% |
| Largest fall, 3 years | -76.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PCVX
What is PCVX's 1-year price change?
Vaxcyte's price rose 22.0% over the past 12 months. With dividends included, the 12-month total return was 22.0%.
What is PCVX's 5-year price change?
Vaxcyte's month-end price rose 165.1% over the 5 years through Oct 2026, a compound annual rate of 21.5%. These figures leave out dividends.
What is PCVX's 52-week high and low?
Vaxcyte's 52-week high is $90.75 and its 52-week low is $42.40. Its latest price of $59.40 on Nov 17, 2026 is 34.5% below the high.
What is PCVX's beta?
Vaxcyte's 1-year beta against the S&P 500 is 1.28, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 28.0%.
Is the PCVX chart free?
Yes. Advanced Charting for PCVX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PCVX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors